reviewed the evidence as to whether any of the available forms of B12 are superior, and concluded that all forms can be converted to the active methyl- and adenosyl-B12 forms, and that there was not sufficient evidence to suggest that any form was superior in terms of bioavailability, biochemical effects or clinical efficacy
The mechanistic rationale builds on earlier work by Kraus and colleagues in Nature (2014), in which adipocyte-specific NNMT knockdown protected mice from diet-induced obesity, establishing NNMT as a metabolic-disease target candidate [2]
Education Fellowship, Inflammatory Bowel Disease, New York University, Langone Medical Center Fellowship, Gastroenterology and Hepatology, New York Medical College/Westchester Medical Center Residency, Internal Medicine, Mount Sinai Hospital M.D., Albert Einstein College of Medicine Areas of Expertise Crohn's Disease Ulcerative Colitis Inflammatory Bowel Disease Celiac Disease Gastroesophageal Reflux Irritable Bowel Syndrome Colorectal Cancer Prevention and Screening Diarrhea/Constipation Fatty Liver Disease Honors and Awards Castle Connolly Top Doctors New York 2022 Castle Connolly Rising Star 2021, 2022 New York Magazine: Top Doctors: 2022 Westchester Magazine: Top Doctors: 2022 Publications Hong SJ, Jang J, Berg D, et
For researchers serious about optimizing their peptide protocols while managing costs effectively, SeekPeptides provides comprehensive resources including the cost calculator , vetted provider recommendations, and a community of experienced researchers who've navigated these exact financial decisions
